BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35178086)

  • 1. The Predictive Value of ACR TI-RADS Classification for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma: A Retrospective Study.
    Zhong M; Zhang Z; Xiao Y; He Y; Chen Y; Huang W; Lu L
    Int J Endocrinol; 2022; 2022():4412725. PubMed ID: 35178086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting papillary thyroid carcinoma cervical lymph node metastases: an algorithm using the American College of Radiology Thyroid Imaging, Reporting and Data System.
    Shangguan R; Kan G; Yang J; Bao L
    Acta Radiol; 2023 Jan; 64(1):101-107. PubMed ID: 34989248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of central compartment nodal metastases in papillary thyroid cancer using TI-RADS score, blood flow, and multifocality.
    Yang JR; Song Y; Chang SJ; Shi LL
    Acta Radiol; 2022 Oct; 63(10):1374-1380. PubMed ID: 34842479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of papillary thyroid metastases to the central compartment: proposal of a model taking into consideration other thyroid conditions.
    Chen Q; Ye X; Wang K; Shen H
    Front Endocrinol (Lausanne); 2023; 14():1299290. PubMed ID: 38089621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
    Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Liu Y; Lv H; Zhang S; Shi B; Sun Y
    Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using ultrasonographic features to predict the outcomes of patients with small papillary thyroid carcinomas: a retrospective study implementing the 2015 ATA patterns and ACR TI-RADS categories.
    Park HM; Lee J; Kwak JY; Park VY; Rho M; Lee M; Yoon JH
    Ultrasonography; 2022 Apr; 41(2):298-306. PubMed ID: 34674455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between BRAF
    Shangguan R; Hu YP; Huang J; Yang SJ; Ye L; Lin RX; Zhu J; Zhang TL; Ying L; Li P
    Acad Radiol; 2019 Feb; 26(2):154-160. PubMed ID: 29941398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergic effect of BRAF
    Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
    Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-institutional study of association of sonographic characteristics with cervical lymph node metastasis in unifocal papillary thyroid carcinoma.
    Zhou L; Yao J; Ou D; Li M; Lei Z; Wang L; Xu D
    Front Endocrinol (Lausanne); 2022; 13():965241. PubMed ID: 36213266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.
    Li X; Zhang H; Zhou Y; Cheng R
    World J Surg Oncol; 2021 Apr; 19(1):138. PubMed ID: 33941214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of Ultrasound Combined with Immunohistochemistry Evaluation of Central Lymph Node Metastasis for the Prognosis of Papillary Thyroid Carcinoma.
    Yao X; Meng Y; Guo R; Lu G; Jin L; Wang Y; Yang D
    Cancer Manag Res; 2020; 12():8787-8799. PubMed ID: 33061575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of central lymph node metastasis in papillary thyroid carcinoma: A retrospective cohort study.
    Tang T; Li J; Zheng L; Zhang L; Shi J
    Int J Surg; 2018 Jun; 54(Pt A):129-132. PubMed ID: 29723673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of a predictive model for central cervical lymph node metastasis of papillary thyroid carcinoma based on ACR TI-RADS score and evaluation of its diagnostic efficacy].
    Chen K; Lv G; Shen H; Wang Y; Wang K; Yang S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Sep; 35(9):773-778. PubMed ID: 34628827
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Study of Ultrasonographic Risk Factors for Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Guang Y; He W; Zhang W; Zhang H; Zhang Y; Wan F
    Front Endocrinol (Lausanne); 2021; 12():791970. PubMed ID: 34917039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the Relevance of the Ultrasonographic Features of Papillary Thyroid Carcinoma and Cervical Lymph Node Metastasis on Conventional and Contrast-Enhanced Ultrasonography.
    Xue T; Liu C; Liu JJ; Hao YH; Shi YP; Zhang XX; Zhang YJ; Zhao YF; Liu LP
    Front Oncol; 2021; 11():794399. PubMed ID: 35004319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic central lymph node dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model.
    Zhong X; Lu Y; Yin X; Wang Q; Wang F; He Z
    Gland Surg; 2022 Feb; 11(2):378-388. PubMed ID: 35284301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic features of follicular variant of papillary thyroid carcinoma (FV-PTC) and diagnostic performance of the 2017 ACR TI-RADS in FV-PTC.
    Zhang F; Chen W
    Endocrine; 2020 Feb; 67(2):379-386. PubMed ID: 31919771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma(cT1N0).
    Zhou B; Qin J
    Eur J Surg Oncol; 2021 Apr; 47(4):882-887. PubMed ID: 33092967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound Elastic Parameters Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.
    Guo JN; Song LH; Yu PY; Yu SY; Deng SH; Mao XH; Xiu C; Sun J
    J Surg Res; 2020 Sep; 253():69-78. PubMed ID: 32335393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.